[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305-203-2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 80, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 657809, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Manmeet Singh Soni CPA", "age": 46, "title": "COO, CFO & Director", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 591499, "exercisedValue": 0, "unexercisedValue": 248000}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Divya  Chari", "age": 56, "title": "Head of Global Clinical Operations", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley D. Spray", "age": 59, "title": "Chief Education & Brand Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 55, "title": "Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 36.7, "open": 34.24, "dayLow": 22.22, "dayHigh": 35.92, "regularMarketPreviousClose": 36.7, "regularMarketOpen": 34.24, "regularMarketDayLow": 22.22, "regularMarketDayHigh": 35.92, "payoutRatio": 0.0, "beta": -0.46, "forwardPE": -61.75, "volume": 24424799, "regularMarketVolume": 24424799, "averageVolume": 3495869, "averageVolume10days": 8100820, "averageDailyVolume10Day": 8100820, "bid": 18.12, "ask": 23.62, "bidSize": 2, "askSize": 20, "marketCap": 27072743424, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 36.91, "fiftyDayAverage": 21.0435, "twoHundredDayAverage": 18.548025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 16904522752, "profitMargins": 0.0, "floatShares": 111183085, "sharesOutstanding": 737680000, "sharesShort": 25090847, "sharesShortPriorMonth": 21221508, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.034, "heldPercentInsiders": 0.84363997, "heldPercentInstitutions": 0.12927, "shortRatio": 7.15, "shortPercentOfFloat": 0.21079999, "impliedSharesOutstanding": 1153750016, "bookValue": 0.527, "priceToBook": 44.525616, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -221315008, "trailingEps": -0.31, "forwardEps": -0.38, "enterpriseToEbitda": -80.153, "52WeekChange": 5.0476804, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 23.465, "targetHighPrice": 44.110363, "targetLowPrice": 29.862314, "targetMeanPrice": 37.212044, "targetMedianPrice": 36.94905, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 412348992, "totalCashPerShare": 0.559, "ebitda": -210902000, "totalDebt": 7218000, "quickRatio": 9.895, "currentRatio": 10.155, "debtToEquity": 1.857, "returnOnAssets": -0.41305, "returnOnEquity": -0.94895, "freeCashflow": -88937128, "operatingCashflow": -142106000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Summit Therapeutics Inc.", "postMarketChangePercent": 3.29512, "postMarketPrice": 24.2382, "postMarketChange": 0.773199, "regularMarketChange": -13.235001, "regularMarketDayRange": "22.22 - 35.92", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3495869, "fiftyTwoWeekLowChange": 21.365, "fiftyTwoWeekLowChangePercent": 10.17381, "fiftyTwoWeekRange": "2.1 - 36.91", "fiftyTwoWeekHighChange": -13.445, "fiftyTwoWeekHighChangePercent": -0.36426443, "fiftyTwoWeekChangePercent": 504.76804, "earningsTimestamp": 1746129600, "earningsTimestampStart": 1746129600, "earningsTimestampEnd": 1746129600, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.31, "epsForward": -0.38, "epsCurrentYear": -0.3145, "priceEpsCurrentYear": -74.61049, "twoHundredDayAverageChangePercent": 0.26509425, "corporateActions": [], "postMarketTime": 1745625585, "regularMarketTime": 1745611201, "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -36.062668, "regularMarketPrice": 23.465, "shortName": "Summit Therapeutics Inc.", "fiftyDayAverageChange": 2.4214993, "fiftyDayAverageChangePercent": 0.115071125, "twoHundredDayAverageChange": 4.916975, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-04-25", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]